Biotech Whitepapers Filter by Date 2025 2024 2023 2022 2021 2020 2019 2018 Category Asia Pacific Landscape Cardiovascular Cell and Gene Therapy CNS Early Phase Gastrointestinal Global Infectious Disease Rare Disease Regulatory/ DDC/ FDA Oncology Metabolic Disorders July 2, 2025 Whitepaper 2025 Global Report for In-Vivo CAR Cell Therapy Explore global trends shaping in-vivo CAR therapies—delivery innovations, clinical trial momentum, and regulatory strategies across oncology and autoimmune diseases.... Download June 12, 2025 Whitepaper Live Biotherapeutic Products Whitepaper 2025 Live biotherapeutic products (LBPs) are gaining momentum in the drug development space, emphasisin... Download March 19, 2025 Whitepaper Optimizing siRNA Therapeutics: Addressing Nonclinical and Manufacturing Complexities Recent FDA approvals of siRNA drugs have revolutionized drug development for this therapeutic modality, which leverag... Download March 10, 2025 Whitepaper Stay Ahead of the Curve: Infectious Disease Clinical Trial Trends & Insights for 2025 Discover the latest data and strategic insights shaping the global infectious disease clinical trial landscape.... Download January 9, 2025 Whitepaper Oncolytic Virus Therapy Clinical Trials Global Landscape Whitepaper 2024 Download the Comprehensive Guide on Global Oncolytic Virus Therapy Clinical Trials... Download November 18, 2024 Whitepaper Vaccine Clinical Trials Global Landscape Whitepaper 2024 Download the Comprehensive Guide on Global Vaccine Clinical Trials... Download September 12, 2024 Whitepaper Cell and Gene Therapies – Global Clinical Trial Landscape (2024) Explore the latest Global Developments in Cell and Gene Therapy Clinical Trials.... Download August 15, 2024 Whitepaper RNA Therapy Clinical Trials Whitepaper – 2024 Explore the future of RNA therapeutics with Novotech's comprehensive whitepaper.... Download June 19, 2024 Whitepaper Radiopharmaceutical Therapy Innovations & Global Clinical Trial Insights 2024 Explore the Latest Innovations, Clinical Trials, and Future Directions in Radiopharmaceuticals... Download May 21, 2024 Whitepaper Comprehensive Report on Antibody-Drug Conjugates Clinical Trials 2024 Download the 2024 clinical trial report on Antibody-Drug Conjugates, covering new drug developments and market insigh... Download March 5, 2024 Whitepaper Precision Oncology Clinical Trials & Statistics 2024 Explore the transformative role of precision oncology in cancer treatment with Novotech CRO's whitepaper.... Download November 24, 2023 Whitepaper Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023) Explore the latest trends in immune checkpoint inhibitors clinical trials.... Download October 30, 2023 Whitepaper Navigating The Biotech Landscape: Insights Into Clinical Trials, Funding Trends, Challenges, And… Biotech Layoffs 2023: Evolving Landscape & Funding Analysis... Download October 19, 2023 Whitepaper The State of CAR-T Research in China China has emerged as a global leader in CAR T-cell therapy research, with over half of all CAR-T clinical trials... Download September 5, 2023 Whitepaper Rare Disease – Global Clinical Trial Landscape (2018-2022) Exploring the Rare Diseases Global Clinical Trials Landscape: Unveiling Challenges, Trends, and Promising Adv... Download March 28, 2023 Whitepaper Navigating the FDA Approval Processes: Capitalize on Regulatory Expertise to Simplify the Complex While global turbulent conditions in the development market over the past few years have introduced novel forces to t... Download March 2, 2023 Whitepaper Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape - Focus On Asia Pacific Asia Pacific has been the fastest growing region in multi-specific monoclonal antibody trials since 2018, with the re... Download February 8, 2023 Whitepaper Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific Asia Pacific has been the fastest growing region in Phase I trials in the last ten years, reaching a share... Download December 16, 2022 Whitepaper Bispecific Antibodies - CMC Considerations Bispecific antibodies (bsAbs) are genetically engineered, recombinant antibodies that consist of two distinct bi... Download December 13, 2022 Whitepaper State of the Global Biotech Landscape: Where the Opportunities Lie Over the last five years, the global biotech and pharmaceutical landscape has witnessed continued growth.... Download November 8, 2022 Whitepaper Non-Clinical Testing Considerations: Drugs vs Devices While drugs and devices differ in their development, clinical trial phases and regulatory guidelines, the most import... Download November 8, 2022 Whitepaper Top Therapeutic Areas APAC-CT LANDSCAPE 2022 The global clinical trial landscape has changed significantly, with the Asia Pacific involved in more than a third of... Download October 25, 2022 Whitepaper The China Biotech Landscape – Opportunities in China and the Path to USFDA Approval Global biopharma companies are looking to capitalize on value creation across different geographic regions through ut... Download September 23, 2022 Whitepaper Understanding the benefits of the Analytical Target Profile (ATP) The 2022 revised version of ICH Q14 describes the ATP as a prospective summary of the performance characteristics des... Download August 5, 2022 Whitepaper Immuno-oncology – Asia pacific – clinical Trial landscape Asia Pacific has shown significant increase in Immuno-oncology trials between 2017 and 2021 and contributes to more than a third... Download August 1, 2022 Whitepaper Modern Technologies Transforming Clinical Development in the APAC Region Traditional clinical trial models are outdated and causes multiple issues for patients, trial sites, and sponsors.... Download June 28, 2022 Whitepaper The role of real world evidence to support US FDA and TGA registrations Real world evidence (RWE) can contribute valuable information to new medicine registrations, in particular for diseases that are difficult to... Download May 26, 2022 Whitepaper Next Generation Sequencing NGS profiling improves patient outcomes while also lowering treatment costs and time to diagnosis for cancer patients... Download May 26, 2022 Whitepaper Evolution of Clinical Trials in the Asia Pacific Region Compared to the US and the EU5 Over the last five years, the global clinical trial landscape has changed significantly. During the analysis period between 2017-2021... Download August 19, 2021 Whitepaper Clinical Development Strategies for Western Biotech Companies in China China’s evolving regulatory reforms have greatly impacted review and approval timelines, streamlined processes, and expedited the development of innovative drugs.... Download May 26, 2021 Whitepaper The Benefits of Asia-Pacific Clinical Trials For Biotechs There has been a continued shift of innovation from big pharma companies to biotechs, with the latter paving the ways... Download August 27, 2019 Whitepaper Asia: Preferred Destination for Clinical Trials Asia is the fastest-growing medicines market globally, with China currently the world’s second-largest market after the US, with medicines spending... Download August 27, 2019 Whitepaper Australia: Preferred Destination for Early Phase Clinical Trials The clinical trials process is complex. It requires substantial investment and skilled human re-sources, and involves risks, not least, the... Download Load More
